4D Molecular Therapeutics, Inc.FDMTNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+14.2%
5Y CAGR+23.3%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+14.2%/yr
vs +52.0%/yr prior
5Y CAGR
+23.3%/yr
Recent deceleration
Acceleration
-37.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
8 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $49.06M | +5.3% |
| 2024 | $46.58M | +27.6% |
| 2023 | $36.49M | +10.9% |
| 2022 | $32.91M | +17.5% |
| 2021 | $28.01M | +62.5% |
| 2020 | $17.24M | +24.1% |
| 2019 | $13.89M | +125.3% |
| 2018 | $6.17M | +76.8% |
| 2017 | $3.49M | - |